Asklepios BioPharma Launches New Biotech Actus Therapeutics Post author:Sam Post published:December 14, 2017 Post category:BioPharma Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics. Source: BioSpace You Might Also Like World's Top 5 Best-Selling Drugs in 2017 December 17, 2017 Alnylam CEO Calls Out Trump's Alleged Immigration Remarks January 14, 2018 Insmed Rockets as Lung Drug Wows in Late-Stage Study September 4, 2017
